- $3.90bn
- $4.76bn
- -$62.07m
- 78
- 29
- 93
- 73
R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 260 | 451 | 793 | 1,374 | -62.1 |
Cost of Revenue | |||||
Gross Profit | 228 | 341 | 547 | 970 | -142 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 190 | 295 | 460 | 913 | -67.1 |
Operating Profit | 69.9 | 156 | 334 | 461 | 5.01 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 61.6 | 149 | 338 | 513 | -41.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 60 | 145 | 315 | 484 | -45.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0 | 0 | 62.6 | 194 | -18.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0 | 0 | 62.6 | 194 | -18.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.069 | 0.08 | 2.01 | 3.91 | -0.226 |
Dividends per Share |